合计减持3074万股,昭衍新药两股东因资金需求全额套现

财中社
Mar 16

  3月16日,昭衍新药(603127/06127)发布公告,股东顾晓磊及其一致行动人顾美芳拟自本减持计划公告之日起3个交易日后的3个月内,通过上海证券交易所以集中竞价的方式合计减持3074万股,占公司总股本的4.1026%。

  当前,顾晓磊及其一致行动人顾美芳分别持有公司A股股份2042万股、1032万股,持股比例分别为2.7251%、1.3775%。

  2025年前三季度,昭衍新药实现收入9.85亿元,归母净利润8071万元。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10